International Myeloma Foundation (IMF)   Report issue

Foundation Phase 2 Phase 3
Founded: North Hollywood CA United States (1990)

Organization Overview

First Clinical Trial
2017
NCT03140943
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

International Myeloma Foundation/Black Swan Research Initiative

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Multiple Myeloma (Phase 3)

Neoplasms, Plasma Cell (Phase 3)

Recurrence (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 6